24 March 2014
Monoclonal Antibody to HCMV Glycoprotein B - MDPI Magazine Highlight
Guest Post by Anamaris Colberg-Poley*
Human cytomegalovirus (HCMV) is the major cause of congenital birth infections in developed countries. HCMV can cause severe birth defects including microcephaly, mental retardation, sensorineural hearing loss, and intrauterine growth restriction. However, because of the potential for teratogenicity and toxic effects, no therapeutic treatment is currently approved by the Food and Drug Administration for congenital HCMV infection. The studies by Lenore Pereira and her colleagues (Zydek et al., 2014. Viruses Special Issue on Recent CMV Research) have significant implications for developing therapies for treatment of congenital HCMV infections, which are seriously lacking at this time. Continue reading →
